Skip to main content

Use of murine models of cytokine-secreting tumor vaccines to study feasibility and toxicity issues critical to designing clinical trials.

Publication ,  Journal Article
Jaffee, EM; Lazenby, A; Meurer, J; Marshall, F; Hauda, KM; Counts, C; Hurwitz, H; Simons, JW; Levitsky, HI; Pardoll, DM
Published in: J Immunother Emphasis Tumor Immunol
July 1995

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Immunother Emphasis Tumor Immunol

DOI

ISSN

1067-5582

Publication Date

July 1995

Volume

18

Issue

1

Start / End Page

1 / 9

Location

United States

Related Subject Headings

  • Tumor Cells, Cultured
  • Mice, Inbred C57BL
  • Mice, Inbred BALB C
  • Mice
  • Melanoma, Experimental
  • Immunotherapy, Adoptive
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Freezing
  • Female
  • Disease Models, Animal
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Jaffee, E. M., Lazenby, A., Meurer, J., Marshall, F., Hauda, K. M., Counts, C., … Pardoll, D. M. (1995). Use of murine models of cytokine-secreting tumor vaccines to study feasibility and toxicity issues critical to designing clinical trials. J Immunother Emphasis Tumor Immunol, 18(1), 1–9. https://doi.org/10.1097/00002371-199507000-00001
Jaffee, E. M., A. Lazenby, J. Meurer, F. Marshall, K. M. Hauda, C. Counts, H. Hurwitz, J. W. Simons, H. I. Levitsky, and D. M. Pardoll. “Use of murine models of cytokine-secreting tumor vaccines to study feasibility and toxicity issues critical to designing clinical trials.J Immunother Emphasis Tumor Immunol 18, no. 1 (July 1995): 1–9. https://doi.org/10.1097/00002371-199507000-00001.
Jaffee EM, Lazenby A, Meurer J, Marshall F, Hauda KM, Counts C, et al. Use of murine models of cytokine-secreting tumor vaccines to study feasibility and toxicity issues critical to designing clinical trials. J Immunother Emphasis Tumor Immunol. 1995 Jul;18(1):1–9.
Jaffee, E. M., et al. “Use of murine models of cytokine-secreting tumor vaccines to study feasibility and toxicity issues critical to designing clinical trials.J Immunother Emphasis Tumor Immunol, vol. 18, no. 1, July 1995, pp. 1–9. Pubmed, doi:10.1097/00002371-199507000-00001.
Jaffee EM, Lazenby A, Meurer J, Marshall F, Hauda KM, Counts C, Hurwitz H, Simons JW, Levitsky HI, Pardoll DM. Use of murine models of cytokine-secreting tumor vaccines to study feasibility and toxicity issues critical to designing clinical trials. J Immunother Emphasis Tumor Immunol. 1995 Jul;18(1):1–9.

Published In

J Immunother Emphasis Tumor Immunol

DOI

ISSN

1067-5582

Publication Date

July 1995

Volume

18

Issue

1

Start / End Page

1 / 9

Location

United States

Related Subject Headings

  • Tumor Cells, Cultured
  • Mice, Inbred C57BL
  • Mice, Inbred BALB C
  • Mice
  • Melanoma, Experimental
  • Immunotherapy, Adoptive
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Freezing
  • Female
  • Disease Models, Animal